SYMPTOM SCIENCE
The science of muscle, joint, bone and body-composition change at menopause
The short answer
Midlife body change is not caused by one hormone and cannot be reduced to willpower. Aging, activity, sleep, stress, medication, illness and genetics all matter. The menopause transition adds another influence: declining and fluctuating estrogen affects bone remodelling, fat distribution and the systems that maintain muscle and connective tissue.
The strongest evidence concerns bone and body composition. Joint pain is commonly reported, but the exact causal pathway is less certain. A new painful or swollen joint still deserves the same medical attention it would receive at any other age.
What happens to muscle and fat
Scale weight and body composition are not the same thing. A person can weigh approximately the same while carrying more fat and less lean tissue.
Longitudinal SWAN data found that fat gain accelerated and lean mass declined during the menopause transition, beginning around the final menstrual period. Overall weight had already been rising with age and did not suddenly accelerate at the start of the transition. In plain English: aging contributes strongly to weight change, while menopause appears to influence what that weight is made of and where fat is stored.
Lower estrogen may affect muscle protein turnover, insulin sensitivity, inflammation and fat distribution. Sleep disruption and hot flashes can also make regular movement and recovery harder. None of this makes change inevitable, but it helps explain why an old routine may produce a different result.
Why strength can slip quietly
Muscle loss is easy to miss because it may first appear as slower recovery, reduced power, difficulty carrying loads or less stability rather than an obvious change in appearance.
Muscle is metabolically active tissue. It supports glucose regulation, bone loading, balance and the ability to remain independent. Resistance exercise therefore matters for health—not simply for changing shape. Adequate dietary protein and sufficient total nutrition also support muscle maintenance, although individual needs vary with health, kidney function and activity.
Joint pain: common, but not specific
Observational studies find more muscle and joint pain among perimenopausal and postmenopausal women than among premenopausal women. Estrogen receptors are present in cartilage, bone, muscle and connective tissue, and estrogen may influence inflammation and pain processing.
However, association is not proof that low estrogen caused a particular painful joint. Osteoarthritis, inflammatory arthritis, tendon injury, thyroid disease, vitamin deficiencies, medication effects and ordinary mechanical strain can overlap. Recent systematic reviews emphasize that the evidence is heterogeneous and that specific diagnoses are often underreported.
Pain with visible swelling, redness, warmth, fever, injury, progressive weakness or loss of function should not be filed under “menopause aches.”
Bone change is different from joint pain
Bones continually remove old tissue and build new tissue. Estrogen helps keep this process balanced. As estrogen falls, bone breakdown can outpace bone formation, with the fastest loss often occurring from late perimenopause through the early postmenopausal years.
Bone loss is usually silent. Osteoporosis does not normally cause generalized aching until a fracture occurs, so feeling fine does not reveal bone density. Canadian screening decisions consider age and additional risks such as earlier menopause, low-trauma fracture, certain medications, low body weight and family history.
Bloating is not the same as fat gain
Bloating may fluctuate with bowel function, diet, constipation, pelvic-floor function and menstrual-cycle changes. Persistent abdominal swelling, pelvic pressure, pain, feeling full very quickly or unexplained weight loss needs assessment. Menopause should not be used to explain away a progressive abdominal change.
What may help
The most useful foundation is progressive resistance training, regular weight-bearing activity, adequate recovery and nutrition that supports muscle and bone. The program should be scaled to current ability; pain, frailty or medical conditions may require guidance from a physiotherapist, kinesiologist or other qualified professional.
An assessment may also consider sleep, iron and thyroid status, medication, injury, inflammatory symptoms, vitamin D intake and bone-health risk. Hormone therapy may help some symptoms and can reduce bone loss while it is being used, but it should not be prescribed solely as a bodybuilding or weight-loss treatment.
Scientific references
- Greendale GA, et al. Changes in body composition and weight during the menopause transition. JCI Insight. 2019.
- El Khoudary SR, et al. The menopause transition and women’s health at midlife: a progress report from SWAN. Menopause. 2019.
- Finkelstein JS, et al. Bone mineral density changes during the menopause transition in a multiethnic cohort of women. Journal of Clinical Endocrinology & Metabolism. 2008.
- Huang F, et al. Musculoskeletal pain among women during the menopausal transition: findings from a longitudinal cohort study. Pain. 2024.
- Bandara P, et al. Musculoskeletal manifestations of perimenopause: a systematic review and meta-analysis. Journal of Bone and Joint Surgery. 2026.
- Marlatt KL, et al. Body composition and cardiometabolic health across the menopause transition. Obesity. 2022.
Educational information—not medical advice. Pain, weakness, weight change and abdominal symptoms have many possible causes. A qualified healthcare professional should assess new, persistent or concerning changes.
